Mechanistic explorations showed that PRMT5 could epigenetically inhibit the expression of the tumor suppressor gene FBW7, leading to increased expression of the cMyc oncogene at the protein level and the subsequent enhancement of aerobic glycolysis, which sustained the proliferation of pancreatic cancer cells (Fig. 7). This evidence concerns the gene FBXW7 and pancreatic neoplasm.